[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Andrew Caravello, DO [@andrewcaravello](/creator/twitter/andrewcaravello) on x 1070 followers Created: 2025-07-17 18:11:17 UTC The Therapy Dr. Makary Just Described Already Exists $NWBO Scott, the trials for this method are not in progress. They are not waiting for funding or early development. They are already complete. In fact, they have been completed across multiple cancers. At Mayo Clinic, this method has already been tested in glioblastoma, metastatic melanoma, recurrent ovarian cancer, and follicular lymphoma. Each time, it followed the same blueprint. Blood is drawn, monocytes are isolated, dendritic cells are matured outside the body, pulsed with tumor antigens, then reinfused to activate the immune system. There was no chemotherapy. No radiation. No surgery. And yet tumors shrank, immune systems responded, and survival extended into years. These were advanced, relapsed, or metastatic patients. Some had no other options. And still, they responded. Safely. Durably. In some cases, completely. Now here is the full breakdown. And why what Dr. Makary said was not a dream. It was already a reality. β Completed Trials at Mayo Using the DCVax Platform Each trial used autologous dendritic cells matured ex vivo Pulsed with tumor lysate or shared tumor antigens Then returned to the patient for immune instruction π§ Glioblastoma (GBM) NCT01957956 β Newly Diagnosed GBM β’ Median survival XXXX months β’ One year survival XX percent β’ Two year survival XX percent β’ Some patients lived beyond five years β’ No grade X or X adverse events NCT03325101 β Recurrent GBM plus Keytruda β’ Treatment-resistant patients β’ Long term survival and immune synergy β’ No toxicity NCT01204684 β GBM and Anaplastic Glioma β’ Median survival XXXX months β’ Systemic immune activation confirmed β’ No serious toxicity πΏ Metastatic Melanoma β’ Stage X and X patients β’ DCs pulsed with melanoma lysate or shared antigens β’ Partial and complete responses β’ T cell activation confirmed β’ No chemo or radiation β’ No serious adverse events πΈ Recurrent Ovarian Cancer β’ DCs pulsed with pooled or autologous lysate β’ Used post-chemotherapy as immune consolidation β’ Delayed recurrence β’ Prolonged progression-free survival β’ No active chemotherapy during vaccination β’ Excellent tolerability 𧬠Follicular Lymphoma β’ Relapsed and refractory patients β’ DCs pulsed with shared lymphoma-associated antigens β’ Tumor shrinkage β’ Documented complete responses β’ Delivered without chemo or radiation β’ Clean safety profile π All These Trials Share the Same Foundation βοΈ Autologous dendritic cells matured outside the body βοΈ Pulsed with tumor lysate or standardized antigens βοΈ No chemotherapy βοΈ No radiation βοΈ No surgery βοΈ Advanced and metastatic patients βοΈ Long term survival βοΈ Immune activation βοΈ Outstanding safety record ποΈ Then Dr. Marty Makary said this on national television βI would like to see more cancer therapies that apply to stage four metastatic disease Therapies that result in what we call a complete pathologic response That is, the cancer melts away There already appears to be some therapies that may enable cancers to shrink and go away completely without chemo, surgery, or radiationβ He did not say the name But every word matches the trials you just read This is the DCVax platform Built on a patented method owned by Northwest Biotherapeutics It does not just work in theory It worked in completed trials Across multiple cancers In patients who had few if any options left And it worked safely π Full breakdown with visuals here Dr. Makary did not say #DCVax But it is exactly what he meant And now the rest of the world can follow XXX engagements  **Related Topics** [$nwbo](/topic/$nwbo) [Post Link](https://x.com/andrewcaravello/status/1945909182655279332)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Andrew Caravello, DO @andrewcaravello on x 1070 followers
Created: 2025-07-17 18:11:17 UTC
The Therapy Dr. Makary Just Described Already Exists
$NWBO
Scott, the trials for this method are not in progress. They are not waiting for funding or early development. They are already complete. In fact, they have been completed across multiple cancers. At Mayo Clinic, this method has already been tested in glioblastoma, metastatic melanoma, recurrent ovarian cancer, and follicular lymphoma. Each time, it followed the same blueprint. Blood is drawn, monocytes are isolated, dendritic cells are matured outside the body, pulsed with tumor antigens, then reinfused to activate the immune system.
There was no chemotherapy. No radiation. No surgery. And yet tumors shrank, immune systems responded, and survival extended into years. These were advanced, relapsed, or metastatic patients. Some had no other options. And still, they responded. Safely. Durably. In some cases, completely.
Now here is the full breakdown. And why what Dr. Makary said was not a dream. It was already a reality.
β Completed Trials at Mayo Using the DCVax Platform
Each trial used autologous dendritic cells matured ex vivo Pulsed with tumor lysate or shared tumor antigens Then returned to the patient for immune instruction
π§ Glioblastoma (GBM)
NCT01957956 β Newly Diagnosed GBM β’ Median survival XXXX months β’ One year survival XX percent β’ Two year survival XX percent β’ Some patients lived beyond five years β’ No grade X or X adverse events
NCT03325101 β Recurrent GBM plus Keytruda β’ Treatment-resistant patients β’ Long term survival and immune synergy β’ No toxicity
NCT01204684 β GBM and Anaplastic Glioma β’ Median survival XXXX months β’ Systemic immune activation confirmed β’ No serious toxicity
πΏ Metastatic Melanoma
β’ Stage X and X patients β’ DCs pulsed with melanoma lysate or shared antigens β’ Partial and complete responses β’ T cell activation confirmed β’ No chemo or radiation β’ No serious adverse events
πΈ Recurrent Ovarian Cancer
β’ DCs pulsed with pooled or autologous lysate β’ Used post-chemotherapy as immune consolidation β’ Delayed recurrence β’ Prolonged progression-free survival β’ No active chemotherapy during vaccination β’ Excellent tolerability
𧬠Follicular Lymphoma
β’ Relapsed and refractory patients β’ DCs pulsed with shared lymphoma-associated antigens β’ Tumor shrinkage β’ Documented complete responses β’ Delivered without chemo or radiation β’ Clean safety profile
π All These Trials Share the Same Foundation
βοΈ Autologous dendritic cells matured outside the body βοΈ Pulsed with tumor lysate or standardized antigens βοΈ No chemotherapy βοΈ No radiation βοΈ No surgery βοΈ Advanced and metastatic patients βοΈ Long term survival βοΈ Immune activation βοΈ Outstanding safety record
ποΈ Then Dr. Marty Makary said this on national television
βI would like to see more cancer therapies that apply to stage four metastatic disease Therapies that result in what we call a complete pathologic response That is, the cancer melts away There already appears to be some therapies that may enable cancers to shrink and go away completely without chemo, surgery, or radiationβ
He did not say the name But every word matches the trials you just read
This is the DCVax platform Built on a patented method owned by Northwest Biotherapeutics It does not just work in theory It worked in completed trials Across multiple cancers In patients who had few if any options left And it worked safely
π Full breakdown with visuals here
Dr. Makary did not say #DCVax But it is exactly what he meant And now the rest of the world can follow
XXX engagements
Related Topics $nwbo
/post/tweet::1945909182655279332